ADVERSE EFFECT OF CIS-DIAMMINEDICHLOROPLATINUM-II (CDDP) ON PORPHYRIN METABOLISM IN MAN

被引:12
作者
ALEXOPOULOS, CG
CHALEVELAKIS, G
KATSOULIS, C
PALLIKARIS, G
机构
关键词
D O I
10.1007/BF00306748
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:165 / 170
页数:6
相关论文
共 18 条
[1]  
BORSOOK H, 1964, ANN NY ACAD SCI, V119, P523
[2]  
CHABNER BA, 1985, CANCER PRINCIPLES PR, V1, P309
[3]  
CHARY K K, 1977, Journal of Clinical Hematology and Oncology, V7, P633
[4]  
COMIS RL, 1980, CISPLATIN CURRENT ST, P485
[5]  
CONNORS BT, 1982, CANCER MED, P843
[6]  
HAYS D, 1976, P AM ASS CANCER RES, V17, P169
[7]  
LEROY AF, 1979, CANCER TREAT REP, V63, P59
[8]   HEMOLYTIC-ANEMIA AFTER CISPLATIN TREATMENT [J].
LEVI, JA ;
ARONEY, RS ;
DALLEY, DN .
BRITISH MEDICAL JOURNAL, 1981, 282 (6281) :2003-2004
[9]   ENZYMES OF HEME METABOLISM IN KIDNEY - REGULATION BY TRACE-METALS WHICH DO NOT FORM HEME COMPLEXES [J].
MAINES, MD ;
KAPPAS, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 1977, 146 (05) :1286-1293
[10]  
MAUZERALL D, 1956, J BIOL CHEM, V219, P435